Medivac(02159) Strategy Re-Ascension: "AI Small Models + Blockchain" Dual-Drive, Reshaping Healthcare Industry Solutions

Dingdong Finance APP has learned that since its listing on the Main Board of the Hong Kong Stock Exchange in 2021, Medivacare (02159) has been continuously deepening its focus on the core healthcare sector. As the medical industry transitions from rapid growth to high-quality development, Medivacare has keenly captured the trend of technological upgrades, establishing a strategic upgrade direction centered on “AI small models + blockchain technology,” committed to solving industry deep-seated pain points through technological innovation, and delivering an impressive digital transformation performance.

A strong business foundation provides confidence for this digital strategic leap. The company’s service network includes over 3,000 tertiary medical institutions, covering major hospitals such as Beijing Tongren Hospital and Fuwai Hospital, and its enterprise client base includes, but is not limited to, eight of the top ten global pharmaceutical companies, laying a high-value medical scenario foundation for subsequent intelligent upgrades.

Looking at internal operations, Medivacare actively introduces intelligent technologies, deeply reconstructing business processes with AI small model tools, significantly optimizing personnel structure, and improving organizational efficiency. This allows the core team to focus more on high-value strategy formulation and medical innovation, laying a solid foundation for continuous business expansion.

On the external empowerment front, Medivacare has iterated and transformed its technological exploration results accumulated in recent years. The company’s technological route has now been comprehensively upgraded to a dual-driven approach of “AI small models + blockchain.” Relying on its self-developed “Giraffe” series digital intelligence platform, Medivacare uses AI small models to perform deep learning and structured processing of massive medical data, combined with blockchain technology to ensure data authenticity and rights confirmation, successfully obtaining a data service provider certificate. This strategic layout not only efficiently explores new pathways for the value transformation of medical data and content but also provides doctors with more precise academic support tools and offers pharmaceutical and medical device companies more penetrating value services.

This strategic upgrade marks the company’s transition from a previous “medical market solution provider” to a “technology enterprise specializing in AI small models + blockchain for the healthcare industry.” Looking ahead, Medivacare will continue to deepen its layout in AI small models and cutting-edge technologies, leading the healthcare service industry toward intelligence and precision, and continuously creating incremental value for the industry.